Refractory major depression successfully treated with electroconvulsive therapy in a patient with Addison disease

J ECT. 2013 Jun;29(2):137-8. doi: 10.1097/YCT.0b013e3182756695.

Abstract

This report describes a 55-year-old woman who had 1 previous episode of major depression that responded favorably to treatment with tricyclic antidepressants. After the development of Addison disease, she experienced a new episode of major depression that failed to respond to adequate treatment with imipramine and was subsequently successfully treated with electroconvulsive therapy (ECT) with steroid cover. The patient did not experience adrenal crisis or adverse effects. After 9 ECT sessions, she attained full remission. These findings support the suggestion that ECT treatment is safe in patients with Addison disease when using 100 mg intravenous hydrocortisone as prophylaxis.

Publication types

  • Case Reports

MeSH terms

  • Addison Disease / complications*
  • Anesthesia
  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / therapeutic use
  • Depressive Disorder, Major / complications*
  • Depressive Disorder, Major / pathology
  • Depressive Disorder, Major / therapy*
  • Depressive Disorder, Treatment-Resistant / complications*
  • Depressive Disorder, Treatment-Resistant / pathology
  • Depressive Disorder, Treatment-Resistant / therapy*
  • Drug Resistance
  • Electroconvulsive Therapy / adverse effects
  • Electroconvulsive Therapy / methods*
  • Humans
  • Hydrocortisone / adverse effects
  • Hydrocortisone / therapeutic use
  • Male
  • Middle Aged
  • Psychiatric Status Rating Scales
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Hydrocortisone